| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/06/2009 | CN100484530C Azithromycin mix suspension grain and method for preparing the same |
| 05/06/2009 | CN100484526C Compounding method of cefpirome sulfate raw material and uses thereof |
| 05/06/2009 | CN100484523C Chinese medicinal preparation of sedum extract and preparation process thereof |
| 05/06/2009 | CN100484521C A nano emulation antibacterial medicine of furacillin and preparation method thereof |
| 05/06/2009 | CN100484516C Cefamandole nafate powder injection, production method of powder injection and raw machine thereof |
| 05/05/2009 | US7528245 Expression control sequence cassette; a nucleotide sequence of a lac operator sequence to which a lacI repressor protein specifically binds a mutated lac; modification of the nucleotide sequence within a T5 promoter/lac operator expression control sequence provides a stable promoter/operator |
| 05/05/2009 | US7528223 Polypeptide encoded by an alternative reading frame of an influenza virus |
| 05/05/2009 | US7528162 such as 3-(4-Chlorophenyl)-N'-((4-chlorophenyl)sulfonyl)-N-(piperidin-1-yl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamidine, used as cannabinoid (CB1) receptor antagonists, for prophylaxis of psychological disorders |
| 05/05/2009 | US7528149 e.g. N-[1-(2-aminoethyl)-4-piperidinyl]-7-methyl-3-(8-quinolinylmethyl)-3H-imidazo[4,5-b]pyridin-2-amine tetrahydrochloride trihydrate; immunostimulant; lower respiratory tract illness during infancy and childhood, asthma, pneumonia |
| 05/05/2009 | US7528113 Method and composition for the treatment of adenoviral ocular infections |
| 05/05/2009 | US7527974 Preparing embryonic stem cells via nuclear transplantation; tissue engineering and the use of embryonic stem in diagnosis, prevention and treatment of cell proliferative, nervous system, muscular and bone disorders; tissue repair |
| 05/05/2009 | US7527946 Angiogenesis and neovascularization inhibition; host cells, recombinant DNA; increased half life and longer vasculature retention time |
| 05/05/2009 | US7527810 Oral immunology using plant product containing hepatitis surface antigen |
| 05/05/2009 | US7527808 Stability and dissolvability; for the therapy of an infectious disease |
| 05/05/2009 | US7527802 For therapy against infections by pathogens such as, for example, enterotoxigenic Escherichia coli (ETEC) and/or for symptoms of diarrheal disease caused thereby |
| 05/05/2009 | CA2417764C Highly absorbable solid preparations containing sitafloxacin and tartaric acid |
| 05/05/2009 | CA2323419C Bactericide |
| 05/05/2009 | CA2265774C Antibacterial composition |
| 05/05/2009 | CA2234980C Cyclopeptide derivatives |
| 05/01/2009 | CA2607771A1 Humanized anti-venezuelan equine encephalitis virus recombinant antibody |
| 05/01/2009 | CA2606828A1 Methods of assessing and treating pulmonary disease |
| 04/30/2009 | WO2009055799A2 Compositions and methods for treatment of diseases of the foot of an animal |
| 04/30/2009 | WO2009055696A1 CARBACEPHEM β-LACTAM ANTIBIOTICS |
| 04/30/2009 | WO2009055445A2 RNA INTERFERENCE MEDIATED INHIBITION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 04/30/2009 | WO2009054992A1 Antimicrobial compositions comprising docusate |
| 04/30/2009 | WO2009054401A1 Anti-viral agent comprising heterocyclic aromatic compound as active ingredient |
| 04/30/2009 | WO2009053604A2 Influenza virus haemagglutinin-specific monoclonal antibodies |
| 04/30/2009 | WO2009053535A2 Peptide vaccine for influenza virus |
| 04/30/2009 | WO2009053368A1 Single ifn-beta fused to a mutated igg fc fragment |
| 04/30/2009 | WO2009053339A2 Cholesterol derivatives of inhibitors of viral fusion |
| 04/30/2009 | WO2009052629A1 Compositions and methods for enhancing immune response |
| 04/30/2009 | WO2009052572A1 Streptococcus m protein, immunogenic fragments, nucleic acids and methods of use |
| 04/30/2009 | WO2009052566A1 Anti-microbial composition |
| 04/30/2009 | WO2009052561A1 Compositions and methods for manipulating an immune response |
| 04/30/2009 | WO2009033733A3 Use of apeptide as a therapeutic agent |
| 04/30/2009 | WO2009007441A3 Crystalline form of (e) 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2 pyrimidinyl]amino]benzonitrile |
| 04/30/2009 | WO2009003711A3 Stereoisomers of tricyclodecan-9-yl-xanthogenate |
| 04/30/2009 | WO2008110351A3 Use of (r) and (s)-2-aryl-propionic acid derivatives as antiseptic agents |
| 04/30/2009 | WO2008017692A3 Methods, uses and compositions for modulating replication of hcv through the farnesoid x receptor (fxr) activation or inhibition |
| 04/30/2009 | WO2007011699A3 Use of non-antibacterial tetracycline formulations for inhibiting bacterial spores |
| 04/30/2009 | WO2005010169A3 High throughput or capillary-based screening for a bioactivity or biomolecule |
| 04/30/2009 | WO2004092199A3 Method for identifying modulators of g protein coupled receptor signaling |
| 04/30/2009 | US20090111851 Antimicrobial Quinolones, Their Compositions and Uses |
| 04/30/2009 | US20090111841 Novel 3,9-Diaza-Spiro[5,5]Undecane Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors |
| 04/30/2009 | US20090111799 Anti-infective agents against intracellular pathogens |
| 04/30/2009 | US20090111798 N-{3-[1-(4-Fluoro-benzyl)-4-hydroxy-2-oxo-2,4a,5,6,7,7a-hexahydro-1H-[1]pyrindin-3-yl]-1,1-dioxo-1,4-dihydro-1 lambda 6-benzo[1,2,4]thiadiazin-7-yl}-methanesulfonamide;hepatitis C viral infections; hepatitis C NS5B polymerase inhibitors; enzyme inhibitors; viricides; side-effect reduction |
| 04/30/2009 | US20090111788 Antibiotic compositions of modified release and process of production thereof |
| 04/30/2009 | US20090111786 Compounds that Prevent Macrophage Apoptosis and Uses Thereof |
| 04/30/2009 | US20090111780 Compositions and methods for treatment of ear canal infection and inflammation |
| 04/30/2009 | US20090111776 Novel tetracycline derivatives as antibacterial agents |
| 04/30/2009 | US20090111774 Pmea lipid conjugates |
| 04/30/2009 | US20090111765 Compositions and methods for immunostimulatory rna oligonucleotides |
| 04/30/2009 | US20090111760 Macrolone compounds |
| 04/30/2009 | US20090111746 Modulating toll-like receptor activity |
| 04/30/2009 | US20090111736 Orally-Absorbed Solid Dose Formulation for Vancomycin |
| 04/30/2009 | US20090110751 Compositions and Methods for Treatment of Diseases of the Foot of an Animal |
| 04/30/2009 | US20090110749 Method and apparatus for producing a stabilized antimicrobial non-toxic electrolyzed saline solution exhibiting potential as a therapeutic |
| 04/30/2009 | US20090110734 Quaternised ammonium cyclodextrin compounds |
| 04/30/2009 | US20090110700 Acellular immunogenic compositions and acellular vaccine compositions against bacillus anthracis |
| 04/30/2009 | US20090110696 Mycobacterial SecA2 Mutants |
| 04/30/2009 | US20090110693 Multimeric complexes of antigens and an adjuvant |
| 04/30/2009 | US20090110690 Hiv Gp120 Crystal Structure and Its Use to Identify Immunogens |
| 04/30/2009 | US20090110687 Compositions and methods related to tim 3, a th1-specific cell surface molecule |
| 04/30/2009 | US20090110684 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 04/30/2009 | US20090110646 Product for Treating the Skin and Mucous Membranes, and Relative Method of Preparation |
| 04/30/2009 | US20090110645 Use of metal astringents for the treatment and prevention of hairy heel warts |
| 04/30/2009 | CA2704098A1 Compositions and methods for enhancing immune response |
| 04/30/2009 | CA2703667A1 Anti-rsv g protein antibodies |
| 04/30/2009 | CA2703475A1 Process for the preparation of macrolide antibacterial agents |
| 04/30/2009 | CA2703299A1 Anti-microbial composition |
| 04/30/2009 | CA2703133A1 Antibody-mediated disruption of quorum sensing in bacteria |
| 04/30/2009 | CA2701286A1 Carbacephem .beta.-lactam antibiotics |
| 04/30/2009 | CA2700430A1 Influenza virus haemagglutinin-specific monoclonal antibodies |
| 04/30/2009 | CA2699894A1 Cholesterol derivatives of inhibitors of viral fusion |
| 04/29/2009 | EP2053126A1 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 04/29/2009 | EP2053123A1 Method of proliferating lak cell |
| 04/29/2009 | EP2053061A1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 04/29/2009 | EP2053056A1 Dendrimeric peptide construct for the prevention of foot-and-mouth disease in animals |
| 04/29/2009 | EP2053039A1 Novel crystal of 5-aminolevulinic acid phosphate and process for production thereof |
| 04/29/2009 | EP2051731A1 Methods for reducing the incidence of mastitis |
| 04/29/2009 | EP2051730A2 Anti-h5n1 influenza activity of the antiviral protein cyanovirin |
| 04/29/2009 | EP2007402A4 Antiviral methods |
| 04/29/2009 | EP1537123B1 Amino-substituted cyclohexane derivatives for the treatment of bacterial infections |
| 04/29/2009 | EP1511472B1 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 04/29/2009 | EP1487863B1 Process for purifying glycopeptide phospohonate derivatives |
| 04/29/2009 | EP1461357B1 Novel hev antigenic peptide and methods |
| 04/29/2009 | EP1461319B1 Quinoline derivatives, synthesis method, and medicines containing said derivatives |
| 04/29/2009 | EP1454136B1 Methods and means for influencing intracellular communication and intracellular organelle transport |
| 04/29/2009 | EP1425022A4 Mutagenic nucleoside analogs for the treatment of viral disease |
| 04/29/2009 | EP1423137B1 Lipopeptide stereoisomers, methods for preparing same, and useful intermediates |
| 04/29/2009 | EP1343807B1 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus |
| 04/29/2009 | EP1296652B1 Topical pharmaceutical formulations and methods of treatment |
| 04/29/2009 | EP1105413B1 Hepatitis c inhibitor tri-peptides |
| 04/29/2009 | EP1043327B1 Phosphonocephem derivatives, process for the preparation of the same, and use thereof |
| 04/29/2009 | EP0876150B2 Non-toxic mutants of pathogenic gram-negative bacteria |
| 04/29/2009 | EP0835315B1 Vaccine for porcine reproductive and respiratory syndrome virus |
| 04/29/2009 | CN201227424Y Preparation method of mouth anaerobe bacteriostat |
| 04/29/2009 | CN101421292A HCV inhibitors |
| 04/29/2009 | CN101421260A Chromen-2-one derivatives |
| 04/29/2009 | CN101420976A Combination approaches for generating immune responses |